Abstract
When a gold standard screening or diagnostic test is not routinely available, it is common to apply two different imperfect tests to subjects from a study population. There is a considerable literature on estimating relevant parameters from the resultant data. In the situation that test sensitivities and specificities are unknown, several inferential strategies have been proposed. One suggestion is to use rough knowledge about the unknown test characteristics as prior information in a Bayesian analysis. Another suggestion is to obtain the statistical advantage of an identified model by splitting the population into two strata with differing disease prevalences. There is some division of opinion in the epidemiological literature on the relative merits of these two approaches. This article aims to shed light on the issue, by applying some recently developed theory on the performance of Bayesian inference in non‐identified statistical models. Copyright © 2004 John Wiley & Sons, Ltd.